Day-to-Day Management and Caregiver Priorities
At a Glance
The most effective day-to-day FTD-ALS care combines predictable routines, simple instructions, early communication supports, safety planning, and caregiver respite. New hallucinations, aggression, wandering, or sudden changes need prompt assessment because they may have treatable causes.
Living with FTD-ALS requires caregivers to manage a unique intersection of physical disability and cognitive change. While the physical symptoms of ALS often demand the most technical care, it is the behavioral and communication challenges of FTD that often create the greatest daily strain. Success in day-to-day management comes from shifting your perspective: viewing difficult behaviors not as “bad choices,” but as symptoms of a changing brain [1][2].
Managing Complex Behaviors
Behavioral symptoms in FTD-ALS can vary widely. While many patients experience profound apathy (a loss of interest and initiative), a meta-analysis found C9orf72 repeat expansions strongly associated with psychotic symptoms and aggression [2][3]. However, these are probabilistic associations, not predictions. New hallucinations, aggression, wandering, or abrupt behavior changes can also reflect pain, constipation, infection, medication effects, sleep loss, hypoxia, or delirium and require prompt medical assessment before attributing the change solely to FTD.
- Apathy and Motivation: Because apathy is a loss of the brain’s “starter motor,” a patient may sit for hours without acting [1]. Rather than asking “What do you want to do?”, which requires complex planning, try providing a single, concrete choice: “It’s time for a walk, let’s get your shoes.”
- Hyperorality: Some studies report up to 29% of FTD patients develop hyperorality, which includes an obsession with eating, a preference for sweets, or even trying to eat non-food items [4]. Managing this often requires environmental control: locking cabinets, removing dangerous small objects, and providing dietitian- and speech-language-pathologist-approved foods (because weight loss and dysphagia are major risks in ALS) [4].
- Behavioral Redirection: When a patient becomes obsessive or aggressive, verbal arguing is rarely successful. Instead, use de-escalation: check for pain or sleep loss, and use “distract and redirect”—introduce a new activity, a favorite snack, or a different room to break the cycle of behavior [5].
Communication Beyond Speech
Communication in FTD-ALS is a “double-edged sword”: the muscles for speech are weakening (dysarthria), and the brain’s ability to process language is changing (aphasia) [6][5].
- Syntactic Comprehension: Many patients struggle to understand complex sentences (e.g., “Before you eat, make sure you take your pill”) [5]. Use short, direct, “one-step” instructions.
- Augmentative and Alternative Communication (AAC): Do not wait for speech to be gone before starting AAC [7].
- Voice and Message Banking: If your loved one still has a clear voice, consider “banking” it now. Voice banking synthesizes their voice for future devices, while message banking records specific phrases in their natural voice [10][11].
Prioritizing Sleep, Safety, and Caregiver Health
Sleep disturbances, including fragmented sleep and excessive daytime sleepiness, are common and can make behavioral symptoms worse the next day [12].
- Treating Sleep Disorders: Addressing primary sleep issues like restless legs or sleep-disordered breathing can significantly improve a patient’s mood and a caregiver’s quality of life [12].
- The “Safety First” Rule: If a patient is wandering at night or acting aggressively, this is a safety crisis. Discuss these symptoms with your neurologist immediately, while noting the significant risks of antipsychotic or sedating drugs. This also means explicitly addressing driving cessation, securing firearms and weapons, monitoring financial vulnerability and medications, and using wandering technology or door alarms [2][12].
- Proactive Respite: Caregiver burnout is a clinical risk in FTD-ALS [12]. Proactive planning—arranging for home health aides, family shifts, or adult day programs—is a medical necessity for the longevity of the care team. You cannot provide high-quality care if you are chronically sleep-deprived or emotionally depleted.
Environment and Routine
A predictable environment reduces the “cognitive load” on a patient. Keeping a strict daily routine for meals, medications, and activity can reduce anxiety and “sundowning” (increased confusion in the evening) [12]. Reducing visual clutter and noise can also help a patient focus on the task at hand and reduce the likelihood of a behavioral outburst.
Common questions in this guide
What should I do if a person with FTD-ALS becomes aggressive, hallucinates, or wanders?
How can I communicate with someone whose speech and language are changing?
How can hyperorality be managed safely in FTD-ALS?
Can sleep problems make FTD-ALS behavior worse?
How can caregivers reduce safety risks at home?
What kinds of respite can help caregivers of someone with FTD-ALS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How can we distinguish whether my loved one’s refusal to follow a command is due to behavioral opposition or a language-processing issue like syntactic comprehension deficit?
- 2.What is our 'crisis plan' if hallucinations, severe aggression, or dangerous wandering occur, and whom do we call first?
- 3.Can we get a referral for a speech-language pathologist who specializes in 'multimodal AAC'—one who can help with both motor weakness and aphasia?
- 4.Does my loved one show signs of sleep-disordered breathing or circadian rhythm disruption that could be making their daytime behavior worse?
- 5.What are the safest pharmacological and behavioral options for managing hyperorality, keeping in mind the need to maintain weight?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
Saxon JA, Thompson JC, Harris JM, et al.
Journal of neurology, neurosurgery, and psychiatry 2020; (91(12)):1304-1311 doi:10.1136/jnnp-2020-323969.
PMID: 33055142 - 2
The Differential Effects of Genetic Mutations in ALS and FTD Genes on Behavioural and Cognitive Changes: A Systematic Review and Meta-Analysis.
Jiménez-García AM, Tortorella ME, Nishimura AL, Arias N
International journal of molecular sciences 2025; (26(13)) doi:10.3390/ijms26136199.
PMID: 40649976 - 3
Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion.
Sellami L, St-Onge F, Poulin S, Laforce R
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2019; (32(2)):120-123 doi:10.1097/WNN.0000000000000189.
PMID: 31205123 - 4
Clinical and imaging correlates of hyperorality in syndromes associated with frontotemporal lobar degeneration.
Altomare D, Bracca V, Premi E, et al.
Psychiatry and clinical neurosciences 2024; (78(12)):818-825 doi:10.1111/pcn.13751.
PMID: 39375835 - 5
Syntactic comprehension deficits across the FTD-ALS continuum.
Kamminga J, Leslie FVC, Hsieh S, et al.
Neurobiology of aging 2016; (41()):11-18 doi:10.1016/j.neurobiolaging.2016.02.002.
PMID: 27103514 - 6
Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.
Long Z, Irish M, Piguet O, et al.
Journal of neurology 2019; (266(4)):921-933 doi:10.1007/s00415-019-09216-0.
PMID: 30707358 - 7
A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States.
Peters B, O'Brien K, Fried-Oken M
Disability and rehabilitation. Assistive technology 2024; (19(4)):1121-1134 doi:10.1080/17483107.2022.2149866.
PMID: 36448513 - 8
Effects of Aided Communication on Communicative Participation for People With Amyotrophic Lateral Sclerosis.
Peters B, Wiedrick J, Baylor C
American journal of speech-language pathology 2023; (32(4)):1450-1465 doi:10.1044/2023_AJSLP-22-00346.
PMID: 37335771 - 9
Communication Matters-Pitfalls and Promise of Hightech Communication Devices in Palliative Care of Severely Physically Disabled Patients With Amyotrophic Lateral Sclerosis.
Linse K, Aust E, Joos M, Hermann A
Frontiers in neurology 2018; (9()):603 doi:10.3389/fneur.2018.00603.
PMID: 30100896 - 10
Stage-Based Communication Rehabilitation in Amyotrophic Lateral Sclerosis (ALS): A Review of Strategies for Enhancing Quality of Life.
Jackson MC, Azarraga RB, Fraix MP, Agrawal DK
Archives of internal medicine research 2025; (8(4)):359-371 doi:10.26502/aimr.0230.
PMID: 41626035 - 11
Palliative care principles in ALS.
Shoesmith C
Handbook of clinical neurology 2023; (191()):139-155 doi:10.1016/B978-0-12-824535-4.00007-0.
PMID: 36599506 - 12
Sleep Disturbances in Frontotemporal Dementia.
McCarter SJ, St Louis EK, Boeve BF
Current neurology and neuroscience reports 2016; (16(9)):85 doi:10.1007/s11910-016-0680-3.
PMID: 27485946
This page offers educational information about managing FTD-ALS and does not replace medical advice. Contact your neurologist or care team promptly about new aggression, hallucinations, wandering, breathing concerns, or other sudden changes.
Get notified when new evidence is published on Frontotemporal dementia with motor neuron disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.